Translational Pharmaceutics® for first in human studies

Reach a pivotal clinical milestone with our phase-specific approaches to test the safety and tolerability of your drug.
Join us for our next webinar
 

Minimizes costs

upfront related to chemistry, manufacturing, and controls (CMC).

Join us for our next webinar
 

Increases precision

in the formulations that are developed and tested, keeping you in-control and on-course of your molecule's development.

Join us for our next webinar
 

Reduces time

to get to pivotal first-in-human studies, so you can achieve the data you need and be on your way to proof-of-concept and later clinical trials more efficiently.

Explore Translational Pharmaceutics®

Beyond optimizing drug products, see how else Translational Pharmaceutics® can be applied to drug programs in these applications.

Image
How does Translational Pharmaceutics work?

Other applications of Translational Pharmaceutics®

  • Optimizing drug products following first-in-human clinical testing 
    We enable rapid formulation and optimization with clinical testing—simplifying reformulation after Phase I and beyond to manage product lifecycle, ensure continued innovation, and meet trial success. This is our RapidFACT® approach, an application of Translational Pharmaceutics®.
  • More efficient, integrated human ADME studies
    Detect formulation issues early and get ahead of regulatory requirements for conducting human ADME studies. Our Synthesis-to-Clinic® ADME studies are enabled using Translational Pharmaceutics® for integrated drug product manufacturing and clinical testing.
Get in touch
Humanity can't afford to wait, so neither can we.